294 related articles for article (PubMed ID: 22702634)
1. Novel strategies in drug discovery of the calcium-sensing receptor based on biased signaling.
Thomsen AR; Smajilovic S; Bräuner-Osborne H
Curr Drug Targets; 2012 Sep; 13(10):1324-35. PubMed ID: 22702634
[TBL] [Abstract][Full Text] [Related]
2. Recent updates on the calcium-sensing receptor as a drug target.
Trivedi R; Mithal A; Chattopadhyay N
Curr Med Chem; 2008; 15(2):178-86. PubMed ID: 18220773
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a calcimimetic with differential effects on parathyroid hormone and calcitonin secretion.
Henley C; Yang Y; Davis J; Lu JY; Morony S; Fan W; Florio M; Sun B; Shatzen E; Pretorius JK; Richards WG; St Jean DJ; Fotsch C; Reagan JD
J Pharmacol Exp Ther; 2011 Jun; 337(3):681-91. PubMed ID: 21422163
[TBL] [Abstract][Full Text] [Related]
4. Strontium is a biased agonist of the calcium-sensing receptor in rat medullary thyroid carcinoma 6-23 cells.
Thomsen AR; Worm J; Jacobsen SE; Stahlhut M; Latta M; Bräuner-Osborne H
J Pharmacol Exp Ther; 2012 Dec; 343(3):638-49. PubMed ID: 22942242
[TBL] [Abstract][Full Text] [Related]
5. [Calcimimetics].
Messa P; Como G; Brezzi B
G Ital Nefrol; 2006; 23(1):12-21. PubMed ID: 16521071
[TBL] [Abstract][Full Text] [Related]
6. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism in stage 5 chronic kidney disease.
Quarles LD
Kidney Int Suppl; 2005 Jul; (96):S24-8. PubMed ID: 15954947
[TBL] [Abstract][Full Text] [Related]
7. The calcium-sensing receptor (CaSR) defends against hypercalcemia independently of its regulation of parathyroid hormone secretion.
Kantham L; Quinn SJ; Egbuna OI; Baxi K; Butters R; Pang JL; Pollak MR; Goltzman D; Brown EM
Am J Physiol Endocrinol Metab; 2009 Oct; 297(4):E915-23. PubMed ID: 19797241
[TBL] [Abstract][Full Text] [Related]
8. Phosphate acts directly on the calcium-sensing receptor to stimulate parathyroid hormone secretion.
Centeno PP; Herberger A; Mun HC; Tu C; Nemeth EF; Chang W; Conigrave AD; Ward DT
Nat Commun; 2019 Oct; 10(1):4693. PubMed ID: 31619668
[TBL] [Abstract][Full Text] [Related]
9. Extracellular calcium-sensing receptors in the parathyroid gland, kidney, and other tissues.
Quarles LD
Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):349-55. PubMed ID: 12815330
[TBL] [Abstract][Full Text] [Related]
10. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
Torres PU
J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
[TBL] [Abstract][Full Text] [Related]
11. Calcium-sensing receptors.
Goodman WG
Semin Nephrol; 2004 Jan; 24(1):17-24. PubMed ID: 14730506
[TBL] [Abstract][Full Text] [Related]
12. Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia.
Corbetta S; Mantovani G; Lania A; Borgato S; Vicentini L; Beretta E; Faglia G; Di Blasio AM; Spada A
Clin Endocrinol (Oxf); 2000 Mar; 52(3):339-48. PubMed ID: 10718832
[TBL] [Abstract][Full Text] [Related]
13. Etelcalcetide decreases the PTH-calcium setpoint without changing maximum and minimum PTH secretion in mice with primary hyperparathyroidism.
Hayashi N; Imanishi Y; Hirakawa T; Kobayashi I; Tateishi T; Miyaoka D; Nagata Y; Mori K; Morioka T; Inoue A; Harada K; Inaba M; Emoto M
J Bone Miner Metab; 2021 May; 39(3):430-438. PubMed ID: 33196900
[TBL] [Abstract][Full Text] [Related]
14. [Basic and clinical aspects of calcimimetics. Structure and function of calcium-sensing receptor].
Fukumoto S
Clin Calcium; 2008 Jan; 18(1):32-6. PubMed ID: 18175869
[TBL] [Abstract][Full Text] [Related]
15. Cinacalcet in hyperfunctioning parathyroid diseases.
Imanishi Y; Inaba M; Kawata T; Nishizawa Y
Ther Apher Dial; 2009 Oct; 13 Suppl 1():S7-S11. PubMed ID: 19765257
[TBL] [Abstract][Full Text] [Related]
16. Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics.
Goodman WG; Quarles LD
Kidney Int; 2008 Aug; 74(3):276-88. PubMed ID: 17568787
[TBL] [Abstract][Full Text] [Related]
17. Relationship between parathyroid calcium-sensing receptor expression and potency of the calcimimetic, cinacalcet, in suppressing parathyroid hormone secretion in an in vivo murine model of primary hyperparathyroidism.
Kawata T; Imanishi Y; Kobayashi K; Kenko T; Wada M; Ishimura E; Miki T; Nagano N; Inaba M; Arnold A; Nishizawa Y
Eur J Endocrinol; 2005 Oct; 153(4):587-94. PubMed ID: 16189180
[TBL] [Abstract][Full Text] [Related]
18. Role of the calcium-sensing receptor in parathyroid gland physiology.
Chen RA; Goodman WG
Am J Physiol Renal Physiol; 2004 Jun; 286(6):F1005-11. PubMed ID: 15130894
[TBL] [Abstract][Full Text] [Related]
19. Functional proteins involved in regulation of intracellular Ca(2+) for drug development: the extracellular calcium receptor and an innovative medical approach to control secondary hyperparathyroidism by calcimimetics.
Nagano N; Nemeth EF
J Pharmacol Sci; 2005 Mar; 97(3):355-60. PubMed ID: 15781990
[TBL] [Abstract][Full Text] [Related]
20. PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor.
Loupy A; Ramakrishnan SK; Wootla B; Chambrey R; de la Faille R; Bourgeois S; Bruneval P; Mandet C; Christensen EI; Faure H; Cheval L; Laghmani K; Collet C; Eladari D; Dodd RH; Ruat M; Houillier P
J Clin Invest; 2012 Sep; 122(9):3355-67. PubMed ID: 22886306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
